Concepedia

D. Kim

DK

9

Publications

424

Citations

9

H-Index

2011

Active since

Affiliations

Seoul National University Hospital(Current)

Peter MacCallum Cancer Centre

Massachusetts General Hospital

Harvard University

European Institute of Oncology

D. Kim is an author at Seoul National University Hospital specializing in medicine, radiation oncology, and cancer therapeutics.

Top concepts

Publications per year

2011–2021

9

Publications

9

Initial phase II results with crizotinib in advanced <i>ALK</i>-positive non-small cell lung cancer (NSCLC): PROFILE 1005.

Lucio Crinò, D. Kim, Gregory J. Riely et al. · Journal of Clinical Oncology · 2011 · 174 citations

, , +14

Updated Results of a Global Phase II Study with Crizotinib in Advanced Alk-Positive Non-Small Cell Lung Cancer (NSCLC)

D. Kim, Myung‐Ju Ahn, Pan‐Chyr Yang et al. · Annals of Oncology · 2012 · 71 citations · Full text

, , +5

P52.03 Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100

Suresh S. Ramalingam, Ferdinandos Skoulidis, Ramaswamy Govindan et al. · Journal of Thoracic Oncology · 2021 · 48 citations

, , +7

Efficacy and Safety of Ceritinib in Patients (Pts) with Advanced Anaplastic Lymphoma Kinase (Alk)-Rearranged (Alk+) Non-Small Cell Lung Cancer (Nsclc): an Update of Ascend-1

Enriqueta Felip, D. Kim, Ranee Mehra et al. · Annals of Oncology · 2014 · 38 citations · Full text

Evaluation of Ceritinib-Treated Patients (Pts) with Anaplastic Lymphoma Kinase Rearranged (Alk+) Non-Small Cell Lung Cancer (Nsclc) and Brain Metastases in the Ascend-1 Study

Alice T. Shaw, Ranee Mehra, D.S.W. Tan et al. · Annals of Oncology · 2014 · 32 citations

, , +9

Rows per page

1–5 of 9